skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Results 1 2 3 next page
Refined by: New Records: New From Last Week remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Alcohol and arrhythmias
Material Type:
Article
Add to My Research

Alcohol and arrhythmias

Cardiologia Hungarica (Budapest), 2024-02, Vol.54 (1), p.48-52

ISSN: 0133-5596 ;EISSN: 1588-0230 ;DOI: 10.26430/CHUNGARICA.2024.54.1.48

Full text available

2
An NIH genetics study targets a long-standing challenge: Diversity: Nearly half the DNA samples in the “All of Us” program are from racial or ethnic minorities. But many biomedical research projects still routinely struggle to attract non-White participants
Material Type:
Newspaper Article
Add to My Research

An NIH genetics study targets a long-standing challenge: Diversity: Nearly half the DNA samples in the “All of Us” program are from racial or ethnic minorities. But many biomedical research projects still routinely struggle to attract non-White participants

The Washington post (Washington, D.C. 1974. Online), 2024-05-07

Copyright WP Company LLC d/b/a The Washington Post May 7, 2024 ;ISSN: 0190-8286 ;EISSN: 2641-9599

Full text available

3
Applied Therapeutics (APLT: $4.75) accelerates rise, up 7.0% in 2 days; +31c [7.0%]
Material Type:
Newsletter Article
Add to My Research

Applied Therapeutics (APLT: $4.75) accelerates rise, up 7.0% in 2 days; +31c [7.0%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 4, 2024

Digital Resources/Online E-Resources

4
Applied Therapeutics (APLT: $4.86) climbs 2.1% strengthening above moving average price; +10c [2.1%]
Material Type:
Newsletter Article
Add to My Research

Applied Therapeutics (APLT: $4.86) climbs 2.1% strengthening above moving average price; +10c [2.1%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 7, 2024

Digital Resources/Online E-Resources

5
Cardiovascular Imaging Journal Issues Research Articles in May 1, 2024 Edition
Material Type:
Newsletter Article
Add to My Research

Cardiovascular Imaging Journal Issues Research Articles in May 1, 2024 Edition

Targeted News Service, 2024

Targeted News Service

Digital Resources/Online E-Resources

6
Clinical application of paediatric serum troponin T testing
Material Type:
Article
Add to My Research

Clinical application of paediatric serum troponin T testing

Archives of disease in childhood, 2024-05, p.archdischild-2023-326719 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-9888 ;EISSN: 1468-2044 ;DOI: 10.1136/archdischild-2023-326719

Full text available

7
Clinical Trial: Assessment of Cardiac Function, Microvascular Function and Cardiac Perfusion in Different Disease Stages of Hypertrophic Cardiomyopathy
Material Type:
Newsletter Article
Add to My Research

Clinical Trial: Assessment of Cardiac Function, Microvascular Function and Cardiac Perfusion in Different Disease Stages of Hypertrophic Cardiomyopathy

US Fed News Service, Including US State News, 2024

Copyright HT Digital Streams Limited May 6, 2024

Digital Resources/Online E-Resources

8
Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results Company Update
Material Type:
Newsletter Article
Add to My Research

Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results Company Update

PR Newswire, 2024

Copyright PR Newswire Association LLC May 7, 2024

Digital Resources/Online E-Resources

9
Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)
Material Type:
Newsletter Article
Add to My Research

Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)

Business Wire, 2024

Copyright Business Wire 2024

Digital Resources/Online E-Resources

10
Effects of trimetazidine on heart failure with reduced ejection fraction and associated clinical outcomes: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Effects of trimetazidine on heart failure with reduced ejection fraction and associated clinical outcomes: a systematic review and meta-analysis

Open heart, 2024-05, Vol.11 (1) [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2023-002579

Full text available

11
Heart arrhythmia
Material Type:
Reports
Add to My Research

Heart arrhythmia

Mayo Clinic Health Information Library : Diseases and Conditions, 2024

2024 Mayo Foundation for Medical Education and Research (MRMER). All rights reserved.

Digital Resources/Online E-Resources

12
Heart disease
Material Type:
Reports
Add to My Research

Heart disease

Mayo Clinic Health Information Library : Diseases and Conditions, 2024

2024 Mayo Foundation for Medical Education and Research (MRMER). All rights reserved.

Digital Resources/Online E-Resources

13
Heart disease
Material Type:
Reports
Add to My Research

Heart disease

Mayo Clinic Health Information Library : Diseases and Conditions, 2024

2024 Mayo Foundation for Medical Education and Research (MRMER). All rights reserved.

Digital Resources/Online E-Resources

14
Heart Failure Journal Issues Research Articles in May 1, 2024 Edition
Material Type:
Newsletter Article
Add to My Research

Heart Failure Journal Issues Research Articles in May 1, 2024 Edition

Targeted News Service, 2024

Targeted News Service

Digital Resources/Online E-Resources

15
Impact of androgenic anabolic steroid use on cardiovascular and mental health in Danish recreational athletes: protocol for a nationwide cross-sectional cohort study as a part of the Fitness Doping in Denmark (FIDO-DK) study
Material Type:
Article
Add to My Research

Impact of androgenic anabolic steroid use on cardiovascular and mental health in Danish recreational athletes: protocol for a nationwide cross-sectional cohort study as a part of the Fitness Doping in Denmark (FIDO-DK) study

BMJ open, 2024-05, Vol.14 (5), p.e078558 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2023-078558

Full text available

16
Incidence and Impact of Takotsubo Syndrome in Hospitalized Patients With COVID-19
Material Type:
Article
Add to My Research

Incidence and Impact of Takotsubo Syndrome in Hospitalized Patients With COVID-19

Texas Heart Institute journal, 2024-05, Vol.51 (1), p.1-10 [Peer Reviewed Journal]

2024 The Authors. Published by The Texas Heart Institute®. ;2024 The Authors. Published by The Texas Heart Institute 2024 ;ISSN: 0730-2347 ;EISSN: 1526-6702 ;DOI: 10.14503/THIJ-23-8309 ;PMID: 38708821

Full text available

17
Intellia Therapeutics (NTLA: $23.60) rises in 4 out of last 5 days, 5-day rise of 14%; +33c [1.4%]
Material Type:
Newsletter Article
Add to My Research

Intellia Therapeutics (NTLA: $23.60) rises in 4 out of last 5 days, 5-day rise of 14%; +33c [1.4%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 4, 2024

Digital Resources/Online E-Resources

18
Intellia Therapeutics (NTLA: $23.72) rises in 4 out of last 5 days, 5-day rise of 7.9%; +12c [0.5%]
Material Type:
Newsletter Article
Add to My Research

Intellia Therapeutics (NTLA: $23.72) rises in 4 out of last 5 days, 5-day rise of 7.9%; +12c [0.5%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 7, 2024

Digital Resources/Online E-Resources

19
Ivabradine ameliorates cardiomyopathy progression in a Duchenne muscular dystrophy model rat
Material Type:
Article
Add to My Research

Ivabradine ameliorates cardiomyopathy progression in a Duchenne muscular dystrophy model rat

Experimental animals, 2024-05, Vol.73 (2), p.145

EISSN: 1881-7122 ;PMID: 37914289

Digital Resources/Online E-Resources

20
Journal of the American College of Cardiology Issues Research Articles in May 14, 2024 Edition
Material Type:
Newsletter Article
Add to My Research

Journal of the American College of Cardiology Issues Research Articles in May 14, 2024 Edition

Targeted News Service, 2024

Targeted News Service

Digital Resources/Online E-Resources

Results 1 2 3 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To

Language 

  1. English  (50)
  2. Chinese  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait